Improved accuracy in differentiating malignant from benign mammographic abnormalities

A simple, improved magnetic resonance imaging method

Vijay P. Khatri, James J. Stuppino, Manuel H. Espinosa, Matthew S. Pollack

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

BACKGROUND. Although several refinements have been reported for breast magnetic resonance imaging (MR1), there has been no uniform agreement by researchers on the optimal method. The authors report a simple and effective MRI method that incorporated the best qualities of other breast MRI methods yet eliminated the complexity of dynamic sequences and computer subtraction. This new method used fat-suppression, a 3D technique, a dedicated breast coil, and quantitation of lesion enhancement. METHODS. Sixty-one mammographically suspicious lesions were evaluated with a fat-suppressed T1-weighted 3D FLASH sequence before and after administration of Gd-DTPA. Abnormalities were evaluated primarily by the degree of lesional enhancement; lesional morphology was assessed as a secondary criterion. For small or multiple lesions, the authors reformatted images to produce MRI findings that corresponded to the mammographic abnormality. To allow accurate pathologic correlation, all subjects underwent stereotactic or excisional biopsy of the suspicious lesions. RESULTS. Using this new method, all 15 breast carcinomas were enhanced with a signal intensity (SI) increase of ≥ 180% (mean = 337%). No benign lesions enhanced at a SI of > 180%. The difference in degree of enhancement between malignant and benign lesions was statistically significant (P < 0.05). There were overlapping degrees of postcontrast enhancement among fibroadenomas (n = 13; mean SI = 70%) and atypical hyperplasias (n =; 11; mean SI = 82%), but morphologic characteristics allowed for discrimination between these two entities. In the remaining benign breast disease lesions, there was minimal enhancement. CONCLUSIONS. 3D fat-suppressed sequencing using this new MRI method accurately discriminated between benign and malignant mammographic abnormalities and eliminated the time-intensive and complex MRI methods without sacrificing accuracy.

Original languageEnglish (US)
Pages (from-to)471-478
Number of pages8
JournalCancer
Volume92
Issue number3
DOIs
StatePublished - Aug 1 2001

Fingerprint

Magnetic Resonance Imaging
Breast
Fats
Fibroadenoma
Gadolinium DTPA
Breast Diseases
Hyperplasia
Research Personnel
Breast Neoplasms
Biopsy

Keywords

  • Atypical hyperplasia
  • Breast
  • Breast radiography
  • Contrast enhancement
  • Magnetic resonance
  • Mammography

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Improved accuracy in differentiating malignant from benign mammographic abnormalities : A simple, improved magnetic resonance imaging method. / Khatri, Vijay P.; Stuppino, James J.; Espinosa, Manuel H.; Pollack, Matthew S.

In: Cancer, Vol. 92, No. 3, 01.08.2001, p. 471-478.

Research output: Contribution to journalArticle

Khatri, Vijay P. ; Stuppino, James J. ; Espinosa, Manuel H. ; Pollack, Matthew S. / Improved accuracy in differentiating malignant from benign mammographic abnormalities : A simple, improved magnetic resonance imaging method. In: Cancer. 2001 ; Vol. 92, No. 3. pp. 471-478.
@article{b48b0749384f43abb3d3e46eacc37ec0,
title = "Improved accuracy in differentiating malignant from benign mammographic abnormalities: A simple, improved magnetic resonance imaging method",
abstract = "BACKGROUND. Although several refinements have been reported for breast magnetic resonance imaging (MR1), there has been no uniform agreement by researchers on the optimal method. The authors report a simple and effective MRI method that incorporated the best qualities of other breast MRI methods yet eliminated the complexity of dynamic sequences and computer subtraction. This new method used fat-suppression, a 3D technique, a dedicated breast coil, and quantitation of lesion enhancement. METHODS. Sixty-one mammographically suspicious lesions were evaluated with a fat-suppressed T1-weighted 3D FLASH sequence before and after administration of Gd-DTPA. Abnormalities were evaluated primarily by the degree of lesional enhancement; lesional morphology was assessed as a secondary criterion. For small or multiple lesions, the authors reformatted images to produce MRI findings that corresponded to the mammographic abnormality. To allow accurate pathologic correlation, all subjects underwent stereotactic or excisional biopsy of the suspicious lesions. RESULTS. Using this new method, all 15 breast carcinomas were enhanced with a signal intensity (SI) increase of ≥ 180{\%} (mean = 337{\%}). No benign lesions enhanced at a SI of > 180{\%}. The difference in degree of enhancement between malignant and benign lesions was statistically significant (P < 0.05). There were overlapping degrees of postcontrast enhancement among fibroadenomas (n = 13; mean SI = 70{\%}) and atypical hyperplasias (n =; 11; mean SI = 82{\%}), but morphologic characteristics allowed for discrimination between these two entities. In the remaining benign breast disease lesions, there was minimal enhancement. CONCLUSIONS. 3D fat-suppressed sequencing using this new MRI method accurately discriminated between benign and malignant mammographic abnormalities and eliminated the time-intensive and complex MRI methods without sacrificing accuracy.",
keywords = "Atypical hyperplasia, Breast, Breast radiography, Contrast enhancement, Magnetic resonance, Mammography",
author = "Khatri, {Vijay P.} and Stuppino, {James J.} and Espinosa, {Manuel H.} and Pollack, {Matthew S.}",
year = "2001",
month = "8",
day = "1",
doi = "10.1002/1097-0142(20010801)92:3<471::AID-CNCR1345>3.0.CO;2-6",
language = "English (US)",
volume = "92",
pages = "471--478",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Improved accuracy in differentiating malignant from benign mammographic abnormalities

T2 - A simple, improved magnetic resonance imaging method

AU - Khatri, Vijay P.

AU - Stuppino, James J.

AU - Espinosa, Manuel H.

AU - Pollack, Matthew S.

PY - 2001/8/1

Y1 - 2001/8/1

N2 - BACKGROUND. Although several refinements have been reported for breast magnetic resonance imaging (MR1), there has been no uniform agreement by researchers on the optimal method. The authors report a simple and effective MRI method that incorporated the best qualities of other breast MRI methods yet eliminated the complexity of dynamic sequences and computer subtraction. This new method used fat-suppression, a 3D technique, a dedicated breast coil, and quantitation of lesion enhancement. METHODS. Sixty-one mammographically suspicious lesions were evaluated with a fat-suppressed T1-weighted 3D FLASH sequence before and after administration of Gd-DTPA. Abnormalities were evaluated primarily by the degree of lesional enhancement; lesional morphology was assessed as a secondary criterion. For small or multiple lesions, the authors reformatted images to produce MRI findings that corresponded to the mammographic abnormality. To allow accurate pathologic correlation, all subjects underwent stereotactic or excisional biopsy of the suspicious lesions. RESULTS. Using this new method, all 15 breast carcinomas were enhanced with a signal intensity (SI) increase of ≥ 180% (mean = 337%). No benign lesions enhanced at a SI of > 180%. The difference in degree of enhancement between malignant and benign lesions was statistically significant (P < 0.05). There were overlapping degrees of postcontrast enhancement among fibroadenomas (n = 13; mean SI = 70%) and atypical hyperplasias (n =; 11; mean SI = 82%), but morphologic characteristics allowed for discrimination between these two entities. In the remaining benign breast disease lesions, there was minimal enhancement. CONCLUSIONS. 3D fat-suppressed sequencing using this new MRI method accurately discriminated between benign and malignant mammographic abnormalities and eliminated the time-intensive and complex MRI methods without sacrificing accuracy.

AB - BACKGROUND. Although several refinements have been reported for breast magnetic resonance imaging (MR1), there has been no uniform agreement by researchers on the optimal method. The authors report a simple and effective MRI method that incorporated the best qualities of other breast MRI methods yet eliminated the complexity of dynamic sequences and computer subtraction. This new method used fat-suppression, a 3D technique, a dedicated breast coil, and quantitation of lesion enhancement. METHODS. Sixty-one mammographically suspicious lesions were evaluated with a fat-suppressed T1-weighted 3D FLASH sequence before and after administration of Gd-DTPA. Abnormalities were evaluated primarily by the degree of lesional enhancement; lesional morphology was assessed as a secondary criterion. For small or multiple lesions, the authors reformatted images to produce MRI findings that corresponded to the mammographic abnormality. To allow accurate pathologic correlation, all subjects underwent stereotactic or excisional biopsy of the suspicious lesions. RESULTS. Using this new method, all 15 breast carcinomas were enhanced with a signal intensity (SI) increase of ≥ 180% (mean = 337%). No benign lesions enhanced at a SI of > 180%. The difference in degree of enhancement between malignant and benign lesions was statistically significant (P < 0.05). There were overlapping degrees of postcontrast enhancement among fibroadenomas (n = 13; mean SI = 70%) and atypical hyperplasias (n =; 11; mean SI = 82%), but morphologic characteristics allowed for discrimination between these two entities. In the remaining benign breast disease lesions, there was minimal enhancement. CONCLUSIONS. 3D fat-suppressed sequencing using this new MRI method accurately discriminated between benign and malignant mammographic abnormalities and eliminated the time-intensive and complex MRI methods without sacrificing accuracy.

KW - Atypical hyperplasia

KW - Breast

KW - Breast radiography

KW - Contrast enhancement

KW - Magnetic resonance

KW - Mammography

UR - http://www.scopus.com/inward/record.url?scp=0035423950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035423950&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(20010801)92:3<471::AID-CNCR1345>3.0.CO;2-6

DO - 10.1002/1097-0142(20010801)92:3<471::AID-CNCR1345>3.0.CO;2-6

M3 - Article

VL - 92

SP - 471

EP - 478

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 3

ER -